Gliomas and seizures

Medical Hypotheses

Volumn 79, Issue 5, 2012, Pages 622-626

  Prakash, O ^a   Lukiw, W J ^a   Peruzzi, F ^a   Reiss, K ^a   Musto, A E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN RECEPTOR; FOCAL ADHESION KINASE; GLUTAMATE AMMONIA LIGASE; PROTEIN TYROSINE KINASE;

ARTICLE; ASTROCYTE; CANCER INVASION; DISEASE PREDISPOSITION; EPILEPTOGENESIS; GLIA CELL; GLIOMA; GROWTH; HUMAN; HYPOTHESIS; METABOLISM; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; SEIZURE; TUMOR CELL;

BRAIN NEOPLASMS; GLIOMA; HUMANS; MODELS, THEORETICAL; SEIZURES;

EID: 84867337295     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.07.037     Document Type: Article

References (58)

1. Adamson C., Kanu O.O., Mehta A.I., et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 2009, 18:1061-1083.
2. Moots P.L., Maciunas R.J., Eisert D.R., Parker R.A., Laporte K., Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol 1995, 52:717-724.
3. Riva M., Salmaggi A., Marchioni E., et al. Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group. Neurol Sci 2006, 27:345-351.
4. Ruda R., Trevisan E., Soffietti R. Epilepsy and brain tumors. Curr Opin Oncol 2010, 22:611-620.
5. Rosati A., Marconi S., Pollo B., et al. Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels. J Neurooncol 2009, 93:319-324.
6. Pitkanen A., Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011, 10:173-186.
7. Kraksta C., Chekenya M. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 2010, 9:135.
8. Akhavan D., Cloughesy T.F., Mischel P.S. MTOR signaling in glioblastoma: lessons learned from bench to bedside. Neuro Oncol 2010, 12:882-889.
9. de Groot J., Sontheimer H. Glutamate and the biology of gliomas. Glia 2010, 59:1181-1189.
10. de Groot M., Toering S.T., Boer K., et al. Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex. Neuro Oncol 2010, 12:265-273.
11. Mikuni N., Ikeda A., Takahashi J.A., et al. A step-by-step resection guided by electrocorticography for nonmalignant brain tumors associated with long-term intractable epilepsy. Epilepsy Behav 2006, 8:560-564.
12. Hayashi T., Umemori H., Mishina M., Yamamoto T. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 1999, 397:72-76.
13. Velcheti V, Levitt D, Prakash O., Preclinical evaluation of bafetinib for treatment of glioblastoma multiforme., American Society of Clinical Oncology, Annual Meeting. (2010).
14. Stettner M.R., Wang W., Nabors L.B., et al. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Cancer Res 2005, 65:5535-5543.
15. Ding Q., Stewart J., Olman M.A., Klobe M.R., Gladson C.L. The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged. J Biol Chem 2003, 278:39882-39891.
16. Lu K.V., Zhu S., Cvrljevic A., et al. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res 2009, 69:6889-6898.
17. Umemori H., Wanaka A., Kato H., Takeuchi M., Tohyama M., Yamamoto T. Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system. Brain Res Mol Brain Res 1992, 16:303-310.
18. Narisawa-Saito M., Silva A.J., Yamaguchi T., Hayashi T., Yamamoto T., Nawa H. Growth factor-mediated Fyn signaling regulates alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons. Proc Natl Acad Sci U S A 1999, 96:2461-2466.
19. Chun J.T., Crispino M., Tocco G. The dual response of protein kinase Fyn to neural trauma: early induction in neurons and delayed induction in reactive astrocytes. Exp Neurol 2004, 185:109-119.
20. Bjarnadottir M., Misner D.L., Haverfield-Gross S., et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J Neurosci 2007, 27:4519-4529.
21. Kojima N., Ishibashi H., Obata K., Kandel E.R. Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-d-aspartate receptor subunit 2B in fyn transgenic mice. Learn Mem 1998, 5:429-445.
22. Chen J.W., Naylor D.E., Wasterlain C.G. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand Suppl 2007, 186:7-15.
23. Huo J.Z., Dykstra C.M., Gurd J.W. Increase in tyrosine phosphorylation of the NMDA receptor following the induction of status epilepticus. Neurosci Lett 2006, 401:266-270.
24. Natarajan M., Hecker T.P., Gladson C.L. FAK signaling in anaplastic astrocytoma and glioblastoma tumors. Cancer J 2003, 9:126-133.
25. Lipinski C.A., Tran N.L., Viso C., et al. Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts. J Neurooncol 2008, 90:181-189.
26. Morimoto K., Fahnestock M., Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 2004, 73:1-60.
27. Ishiuchi S. New roles of glutamate receptors in glias and gliomas. Brain Nerve 2009, 61:753-764.
28. Scharfman H.E. Brain-derived neurotrophic factor and epilepsy-a missing link?. Epilepsy Curr 2005, 5:83-88.
29. Kitaura J., Kawakami Y., Maeda-Yamamoto M., Horejsi V., Kawakami T. Dysregulation of Src family kinases in mast cells from epilepsy-resistant ASK versus epilepsy-prone EL mice. J Immunol 2007, 178:455-462.
30. Schunemann D.P., Grivicich I., Regner A., et al. Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line. Pathol Oncol Res 2010, 16:285-293.
31. Fukai J., Yokote H., Yamanaka R., Arao T., Nishio K., Itakura T. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line. Mol Cancer Ther 2008, 7:2768-2778.
32. Filosa A., Paixao S., Honsek S.D., et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci 2009, 12:1285-1292.
33. Tanaka K., Watase K., Manabe T., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
34. Henshall D.C., Murphy B.M. Modulators of neuronal cell death in epilepsy. Curr Opin Pharmacol 2008, 8:75-81.
35. Kohling R., Senner V., Paulus W., Speckmann E.J. Epileptiform activity preferentially arises outside tumor invasion zone in glioma xenotransplants. Neurobiol Dis 2006, 22:64-75.
36. Senner V., Kohling R., Puttmann-Cyrus S., Straub H., Paulus W., Speckmann E.J. A new neurophysiological/neuropathological ex vivo model localizes the origin of glioma-associated epileptogenesis in the invasion area. Acta Neuropathol 2004, 107:1-7.
37. Patt S., Steenbeck J., Hochstetter A., et al. Source localization and possible causes of interictal epileptic activity in tumor-associated epilepsy. Neurobiol Dis 2000, 7:260-269.
38. Vezzani A., Hoyer D. Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. Eur J Neurosci 1999, 11:3767-3776.
39. Galanopoulou A.S., Moshe S.L. The epileptic hypothesis: developmentally related arguments based on animal models. Epilepsia 2009, 50(Suppl 7):37-42.
40. Aronica E., Gorter J.A., Jansen G.H., Leenstra S., Yankaya B., Troost D. Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol 2001, 101:449-459.
41. LeBeau F.E., Traub R.D., Monyer H., Whittington M.A., Buhl E.H. The role of electrical signaling via gap junctions in the generation of fast network oscillations. Brain Res Bull 2003, 62:3-13.
42. Takano T., Lin J.H., Arcuino G., Gao Q., Yang J., Nedergaard M. Glutamate release promotes growth of malignant gliomas. Nat Med 2001, 7:1010-1015.
43. Chung W.J., Lyons S.A., Nelson G.M., et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 2005, 25:7101-7110.
44. Pogue A.I., Cui J.G., Li Y.Y., Zhao Y., Culicchia F., Lukiw W.J. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 2010, 476:18-22.
45. Lukiw W.J., Cui J.G., Li Y.Y., Culicchia F. Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme (GBM). J Neurooncol 2009, 91:27-32.
46. Sethi P., Lukiw W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009, 459:100-104.
47. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nature Rev 2002, 2:569-579.
48. Skog J., Wurdinger T., van Rijn S., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
49. Zhang Y., Liu D., Chen X., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol cell 2010, 39:133-144.
50. Valenti R., Huber V., Iero M., Filipazzi P., Parmiani G., Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67:2912-2915.
51. Srinivasan S., Patric I.R., Somasundaram K. A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One 2011, 6:e17438.
52. Aronica E., Fluiter K., Iyer A., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010, 31:1100-1107.
53. Musto A.E., Samii M. Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. Epilepsia 2011, 52:551-561.
54. Zhou X., Ren Y., Moore L., et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab Invest 2010, 90:144-155.
55. Rao X., Di Leva G., Li M., et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011, 30:1082-1097.
56. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008, 68:8164-8172.
57. Hu K., Zhang C., Long L., et al. Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. Neurosci Lett 2011, 488:252-257.
58. Elias L.A., Turmaine M., Parnavelas J.G., Kriegstein A.R. Connexin 43 mediates the tangential to radial migratory switch in ventrally derived cortical interneurons. J Neurosci 2010, 30:7072-7077.